Figure 5 from Structurally Oriented Classification of &lt;i&gt;FOXA1&lt;/i&gt; Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes

Exploring foci of: doi.org Figure 5 from Structurally Oriented Classification of &lt;i&gt;FOXA1&lt;/i&gt; Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic Subtypes March 2025 • Justin H. Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, Sharon Wu, Jason J. Kwon, Eamon Toye, David Moline, Mark G. Evans, Andrew Elliott,… &lt;p&gt;Molecular associations by &lt;i&gt;FOXA1&lt;/i&gt; alteration class. Percentages of (&lt;b&gt;A&lt;/b&gt;) &lt;i&gt;TMPRSS2–ERG&lt;/i&gt; fusions, (&lt;b&gt;B&lt;/b&gt;) &lt;i&gt;TP53&lt;/i&gt; mutations, (&lt;b&gt;C&lt;/b&gt;) MSI-high status, and (&lt;b&gt;D&lt;/b&gt;) TMB-high status based on &lt;i&gt;FOXA1&lt;/i&gt; alteration classes. All &lt;i&gt;q&lt;/i&gt; values are relative to WT cases. Percentages of select genetic alterations comparing WT and (&lt;b&gt;E&lt;/b&gt;) class 1B, (&lt;b&gt;F&lt;/b&… Open Article Page